Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Clary

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Anticancer Research|December 8, 2019
Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse ModelGuangwei Zhu, Ming Zhao, Qinghong Han, et al.
Biochemical and Biophysical Research Communications|August 19, 2019
Efficacy of oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil on primary colon cancer in a patient-derived orthotopic xenograft mouse modelJun Ho Park, Ming Zhao, Qinghong Han, et al.
JAMA Surgery|December 18, 2024
Leveraging Lean Methodology to Improve Compliance With Work-Hour RestrictionsJ Jeffery Reeves, Nicole Goldhaber, Hannah Hollandsworth, et al.
Tissue & Cell|November 25, 2019
Oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil regressed a colon cancer growing on the peritoneal surface in a patient-derived orthotopic xenograft mouse modelJun Ho Park, Qinghong Han, Ming Zhao, et al.
JAMA Surgery|November 26, 2025
Data and the Art of Surgical Preference Card MaintenanceSean Perez, Adir Mancebo, Patricia Lopez, et al.
Anticancer Research|July 3, 2019
Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively <i>via</i> Red Fluorescent Protein Labeled Stromal CellsJun Ho Park, Ming Zhao, Hiromichi Oshiro, et al.
Tissue & Cell|June 3, 2018
MEK inhibitor trametinib in combination with gemcitabine regresses a patient-derived orthotopic xenograft (PDOX) pancreatic cancer nude mouse modelKei Kawaguchi, Kentaro Igarashi, Kentaro Miyake, et al.
Annals of Surgical Oncology|January 9, 2009
Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancyJeremiah L Deneve, Timothy M Pawlik, Steve Cunningham, et al.
Scientific Reports|April 11, 2018
Positive Surgical Margins in the 10 Most Common Solid CancersRyan K Orosco, Viridiana J Tapia, Joseph A Califano, et al.
Anticancer Research|September 15, 2019
Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse ModelHiromichi Oshiro, Yasunori Tome, Tasuku Kiyuna, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Anticancer Research|December 8, 2019
Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse ModelGuangwei Zhu, Ming Zhao, Qinghong Han, et al.
Biochemical and Biophysical Research Communications|August 19, 2019
Efficacy of oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil on primary colon cancer in a patient-derived orthotopic xenograft mouse modelJun Ho Park, Ming Zhao, Qinghong Han, et al.
JAMA Surgery|December 18, 2024
Leveraging Lean Methodology to Improve Compliance With Work-Hour RestrictionsJ Jeffery Reeves, Nicole Goldhaber, Hannah Hollandsworth, et al.
Tissue & Cell|November 25, 2019
Oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil regressed a colon cancer growing on the peritoneal surface in a patient-derived orthotopic xenograft mouse modelJun Ho Park, Qinghong Han, Ming Zhao, et al.
JAMA Surgery|November 26, 2025
Data and the Art of Surgical Preference Card MaintenanceSean Perez, Adir Mancebo, Patricia Lopez, et al.
Anticancer Research|July 3, 2019
Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively <i>via</i> Red Fluorescent Protein Labeled Stromal CellsJun Ho Park, Ming Zhao, Hiromichi Oshiro, et al.
Tissue & Cell|June 3, 2018
MEK inhibitor trametinib in combination with gemcitabine regresses a patient-derived orthotopic xenograft (PDOX) pancreatic cancer nude mouse modelKei Kawaguchi, Kentaro Igarashi, Kentaro Miyake, et al.
Annals of Surgical Oncology|January 9, 2009
Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancyJeremiah L Deneve, Timothy M Pawlik, Steve Cunningham, et al.
Scientific Reports|April 11, 2018
Positive Surgical Margins in the 10 Most Common Solid CancersRyan K Orosco, Viridiana J Tapia, Joseph A Califano, et al.
Anticancer Research|September 15, 2019
Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse ModelHiromichi Oshiro, Yasunori Tome, Tasuku Kiyuna, et al.
Pageof 4